Re: mixing J&J and mRNA vaccines -- assuming this combination does produce a durable immune response, I wonder if it might decrease the incidence of myocarditis reactions? Perhaps interesting in this regard is an article published last week (https://www.mdpi.com/2076-393X/9/10/1186/htm) suggesting a mechanism by which the reaction occurs, and recommending increasing the time interval between doses as a way to mitigate it.
Politico is claiming that Novavax still can't produce pure vaccine, and they predict that the FDA won't approve the Novavax product until next year at the earliest. I'm not totally persuaded (the story doesn't seem to know about their deal with the Serum Institute, for instance) but it's already crushing their stock price.
Re: mixing J&J and mRNA vaccines -- assuming this combination does produce a durable immune response, I wonder if it might decrease the incidence of myocarditis reactions? Perhaps interesting in this regard is an article published last week (https://www.mdpi.com/2076-393X/9/10/1186/htm) suggesting a mechanism by which the reaction occurs, and recommending increasing the time interval between doses as a way to mitigate it.
Did you see this story?
https://www.politico.com/news/2021/10/19/novavax-vaccine-rush-process-global-campaign-516298
Politico is claiming that Novavax still can't produce pure vaccine, and they predict that the FDA won't approve the Novavax product until next year at the earliest. I'm not totally persuaded (the story doesn't seem to know about their deal with the Serum Institute, for instance) but it's already crushing their stock price.